BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hasan S, Colonias A, Mickus T, VanDeusen M, Wegner RE. Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experience. Thorac Cancer 2018;9:699-706. [PMID: 29697204 DOI: 10.1111/1759-7714.12635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wilkie JR, Lipson R, Johnson MC, Williams C, Moghanaki D, Elliott D, Owen D, Atluri N, Jolly S, Chapman CH. Use and Outcomes of SBRT for Early Stage NSCLC Without Pathologic Confirmation in the Veterans Health Care Administration. Adv Radiat Oncol 2021;6:100707. [PMID: 34409207 DOI: 10.1016/j.adro.2021.100707] [Reference Citation Analysis]
2 Koh TL, Ong WL, Farrugia B, Leong T, Lapuz C, Lim A. To biopsy or not to biopsy? Outcomes following stereotactic body radiotherapy (SBRT) for biopsy-confirmed versus radiologically-diagnosed primary lung cancer in a single Australian institution. Asia Pac J Clin Oncol 2021. [PMID: 34187094 DOI: 10.1111/ajco.13614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Vlaskou Badra E, Baumgartl M, Fabiano S, Jongen A, Guckenberger M. Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research. Transl Lung Cancer Res 2021;10:1930-49. [PMID: 34012804 DOI: 10.21037/tlcr-20-860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kowalchuk RO, Waters MR, Baliga S, Richardson KM, Spencer KM, Larner JM, Kersh CR. Stereotactic body radiation therapy for empirically treated hypermetabolic lung lesions: a single-institutional experience identifying the Charlson score as a key prognostic factor. Transl Lung Cancer Res 2020;9:1862-72. [PMID: 33209608 DOI: 10.21037/tlcr-20-469] [Reference Citation Analysis]
5 Wegner RE, Abel S, Horne ZD, Hasan S, Colonias A, Verma V. Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid. Lung Cancer Manag 2019;8:LMT14. [PMID: 31807142 DOI: 10.2217/lmt-2019-0003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Abel S, Hasan S, Horne ZD, Colonias A, Wegner RE. Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications. Lung Cancer Manag 2019;8:LMT09. [PMID: 31044018 DOI: 10.2217/lmt-2018-0013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]